Head and Neck Diseases by Alexandros G.Sfakianakis: BCL2L12 protein overexpression is associated with favorable outcome in diffuse large B-cell lymphoma patients in the rituximab era.

Τρίτη 20 Μαρτίου 2018

BCL2L12 protein overexpression is associated with favorable outcome in diffuse large B-cell lymphoma patients in the rituximab era.

http:--www.tandfonline.com-templates-jsp

BCL2L12 protein overexpression is associated with favorable outcome in diffuse large B-cell lymphoma patients in the rituximab era.

Leuk Lymphoma. 2016 09;57(9):2199-203

Authors: Papageorgiou SG, Kontos CK, Foukas PG, Panopoulou E, Vasilatou D, Rapti SM, Gkontopoulos K, Bazani E, Panayiotides IG, Dimitriadis G, Scorilas A, Pappa V

PMID: 27442703 [PubMed - indexed for MEDLINE]

http://ift.tt/2FNDJ6h

Head and Neck Diseases by Alexandros G.Sfakianakis

Τρίτη 20 Μαρτίου 2018

BCL2L12 protein overexpression is associated with favorable outcome in diffuse large B-cell lymphoma patients in the rituximab era.

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου